Proteomic analysis of porcine mesenchymal stem cells derived from bone marrow and umbilical cord: implication of the proteins involved in the higher migration capability of bone marrow mesenchymal stem cells

IntroductionMesenchymal stem cells (MSCs) have the ability to proliferate in vivo with a large variety of differentiation potentials and therefore are widely used as an ideal material for cell therapy. MSCs derived from pig and human sources are similar in many aspects, such as cell immunophenotype and functional characteristics. However, differences in proteomics and the molecular mechanisms of cell functions between porcine bone marrow MSCs (BM-MSCs) and umbilical cord MSCs (UC-MSCs) are largely unknown. To the best of our knowledge, MSCs collected from different tissue have specific phenotype and differentiation ability in response to microenvironment, known as a niche.MethodsPorcine BM-MSCs and UC-MSCs were evaluated with flow cytometric and adipogenic and osteogenic differentiation analyses. We used isobaric tagging for relative and absolute quantitation (iTRAQ), combined with liquid chromatography-tandem mass spectrometry, to identify differentially expressed proteins (DEPs) between these two types of MSCs. Kyoto Encyclopedia of Genes and Genomes pathway and phenotype analyses were used to understand the links between cell migration ability and DEPs.ResultsTwo separate iTRAQ experiments were conducted, identifying 95 DEPs (95% confidence interval). Five of these proteins were verified by Western blotting. These 95 DEPs were classified in terms of biological regulation, metabolic process, developmental process, immune system process, reproduction, death, growth, signaling, localization, response to stimulus, biological adhesion, and cellular component organization. Our study is the first to show results indicating that porcine BM-MSCs have a higher migration capability than UC-MSCs. Finally, one of the DEPs, Vimentin, was verified to have a positive role in MSC migration.ConclusionsThese results represent the first attempt to use proteomics specifically targeted to porcine MSCs of different tissues. The identified components should help reveal a variety of tissue-specific functions in tissue-derived MSC populations and could serve as important tools for the regeneration of particular tissues in future stem cell-based tissue engineering studies using animal models.

[1]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[2]  Paul Martin,et al.  Impaired wound healing in embryonic and adult mice lacking vimentin. , 2000, Journal of cell science.

[3]  R. Danner,et al.  Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock. , 2003, International immunopharmacology.

[4]  M. Czyz,et al.  Thymosin beta 4 induces the synthesis of plasminogen activator inhibitor 1 in cultured endothelial cells and increases its extracellular expression. , 2004, Blood.

[5]  J. Tavaré,et al.  Proteome analysis of adipogenesis , 2004, Proteomics.

[6]  W. Ansorge,et al.  Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. , 2005, Experimental hematology.

[7]  S. Jalkanen,et al.  Vimentin function in lymphocyte adhesion and transcellular migration , 2006, Nature Cell Biology.

[8]  Y. Bahk,et al.  A proteomic analysis during serial subculture and osteogenic differentiation of human mesenchymal stem cell , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[9]  R. Izadpanah,et al.  Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue , 2006, Journal of cellular biochemistry.

[10]  C. Cierniewski,et al.  Adhesive and Proteolytic Phenotype of Migrating Endothelial Cells Induced by Thymosin β‐4 , 2007, Annals of the New York Academy of Sciences.

[11]  K. Jang,et al.  A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma. , 2007, Oncology reports.

[12]  J. Fransen,et al.  Cysts of PRKCSH mutated polycystic liver disease patients lack hepatocystin but express Sec63p , 2008, Histochemistry and Cell Biology.

[13]  Saijuan Chen,et al.  RIG-I plays a critical role in negatively regulating granulocytic proliferation , 2008, Proceedings of the National Academy of Sciences.

[14]  A. Pintzas,et al.  Fra‐1 regulates vimentin during Ha‐RAS‐induced epithelial mesenchymal transition in human colon carcinoma cells , 2007, International journal of cancer.

[15]  Chun-ling Meng,et al.  Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord, and placenta: Implication in the migration , 2009, Proteomics.

[16]  Xian-hui He,et al.  Quantitative Proteomics Analysis of Chondrogenic Differentiation of C3H10T1/2 Mesenchymal Stem Cells by iTRAQ Labeling Coupled with On-line Two-dimensional LC/MS/MS* , 2009, Molecular & Cellular Proteomics.

[17]  J. Yoo,et al.  Differential Expression Of Cell Surface Proteins In Human Bone Marrow Mesenchymal Stem Cells Cultured With Or Without Basic Fibroblast Growth Factor Containing Medium , 2009, Alzheimer's & Dementia.

[18]  S. Lehmann,et al.  Comparative proteomic analysis of human mesenchymal and embryonic stem cells: Towards the definition of a mesenchymal stem cell proteomic signature , 2009, Proteomics.

[19]  I. Gipson,et al.  Galectin-3 promotes lamellipodia formation in epithelial cells by interacting with complex N-glycans on α3β1 integrin , 2009, Journal of Cell Science.

[20]  Betül Çelebi,et al.  Proteome analysis of rat bone marrow mesenchymal stem cell subcultures. , 2009, Journal of proteome research.

[21]  K. Mrozik,et al.  Proteomic characterization of mesenchymal stem cell-like populations derived from ovine periodontal ligament, dental pulp, and bone marrow: analysis of differentially expressed proteins. , 2010, Stem cells and development.

[22]  Betül Çelebi,et al.  Proteome analysis of rat bone marrow mesenchymal stem cell differentiation. , 2010, Journal of proteome research.

[23]  D. Schaffer,et al.  Transforming Growth Factor‐β and Notch Signaling Mediate Stem Cell Differentiation into Smooth Muscle Cells , 2010, Stem cells.

[24]  R. Knuechel,et al.  The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds. , 2010, Biomaterials.

[25]  Soo-Hyun Lee,et al.  Over-expression of thymosin beta 4 promotes abnormal tooth development and stimulation of hair growth. , 2010, The International journal of developmental biology.

[26]  J. Kang,et al.  Actin-sequestering protein, thymosin beta-4, is a novel hypoxia responsive regulator , 2010, Clinical & Experimental Metastasis.

[27]  Soo-Jin Jeong,et al.  Proteomic analysis of mesenchymal stem‐like cells derived from ovarian teratoma: Potential role of glutathione S‐transferase M2 in ovarian teratoma , 2011, Proteomics.

[28]  B. Zetter,et al.  Regenerative protein thymosin β‐4 is a novel regulator of purinergic signaling , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  M. Gale,et al.  Immune signaling by RIG-I-like receptors. , 2011, Immunity.

[30]  Humberto E. Trejo,et al.  Vimentin is sufficient and required for wound repair and remodeling in alveolar epithelial cells , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  W. Liu,et al.  Galectin-3 regulates intracellular trafficking of epidermal growth factor receptor through Alix and promotes keratinocyte migration , 2012, The Journal of investigative dermatology.

[32]  Huanming Yang,et al.  An atlas of DNA methylomes in porcine adipose and muscle tissues , 2012, Nature Communications.

[33]  J. Chae,et al.  Proteomic Validation of Multifunctional Molecules in Mesenchymal Stem Cells Derived from Human Bone Marrow, Umbilical Cord Blood and Peripheral Blood , 2012, PloS one.

[34]  A. Sonnenberg,et al.  Epigenetic Regulation of Galectin-3 Expression by β1 Integrins Promotes Cell Adhesion and Migration* , 2012, The Journal of Biological Chemistry.

[35]  D. Hwang,et al.  Proteomic analysis of microvesicles derived from human mesenchymal stem cells. , 2012, Journal of proteome research.

[36]  S. Zanata,et al.  De novo galectin-3 expression influences the response of melanoma cells to isatin-Schiff base copper (II) complex-induced oxidative stimulus. , 2013, Chemico-biological interactions.

[37]  J. Nyalwidhe,et al.  Variable Metastatic Potentials Correlate with Differential Plectin and Vimentin Expression in Syngeneic Androgen Independent Prostate Cancer Cells , 2013, PloS one.

[38]  Cécile Boscher,et al.  Galectin-3– and phospho-caveolin-1–dependent outside-in integrin signaling mediates the EGF motogenic response in mammary cancer cells , 2013, Molecular biology of the cell.

[39]  H. Kidoya,et al.  Galectin-3 accelerates M2 macrophage infiltration and angiogenesis in tumors. , 2013, The American journal of pathology.

[40]  K. Bayless,et al.  Vimentin as an Integral Regulator of Cell Adhesion and Endothelial Sprouting , 2014, Microcirculation.